CA-TRADESHIFT
Tradeshift, the leader in supply chain payments and marketplaces, has announced the addition of four new hires hailing from Microsoft, Ariba, SAP and Oracle. On the heels of Tradeshift’s latest funding news, in which the company announced $240 million in funding, the company welcomes these seasoned veterans to help the company reach its strategic goals for 2020.
The four new hires represent deep experience in a range of business leadership initiatives including network, product and sales. The roles include:
Janet Heppner-Jones, VP of North America Sales : Heppner-Jones has an impressive background in digital solutions and SaaS sales leadership, most recently leading the America's sales team at Baker Hughes. Her diverse background has provided her with global executive responsibilities in many multinational companies across many business functions, including SAP, ABB, Dassault Systems, and Ariba. Heppner-Jones began her career as a Sales Representative with IBM where she earned the prestigious Eagle Award (top 1% of the sales force). At Tradeshift, Heppner-Jones will continue and accelerate the 60 percent growth rate, increase deal size, and work with partners in North America.
Tony Alvarez, VP of Network : Alvarez will be responsible for Tradeshift seller onboarding, GMV growth, and the Tradeshift early payment and Marketplace offerings. Prior to joining, Alvarez spent 10 years with SAP Ariba serving in several senior leadership positions in the commercial and operational functions, most recently serving as SVP of Ariba Business Network Solutions. He has experience in large deal negotiations, network monetization, and marketplace development. Alvarez began his career with Arthur Andersen Consulting, then went on to earn his MBA at Harvard.
Henry Goh, VP of APAC Sales: Goh will be leading all APAC sales as the VP of Sales, APAC. For the past 10 years, Goh has been running APAC sales for Ariba. Prior to Ariba, he was at PwC and Oracle leading teams across Asia. Goh has a wealth of experience in “go-to-market” strategy in APAC. He has experience in large deal negotiations including cultivating, developing, formulating and constructing deals.
Raphael Bres, Chief Product Officer: Bres brings to Tradeshift over 20 years experience building ERP’s at Workday, FinancialForce, and Peoplesoft, built on a solid foundation from Deloitte, Oracle and Microsoft. While Bres will be based out of our San Francisco office, he also brings strong global experience, having not only held international roles but also earning his graduate degrees from Université Paris Dauphine.
“This is a pivotal year for Tradeshift and we’re hyper-focused on the areas of the business that will give us the greatest momentum and lead us to profitability,” said Christian Lanng, CEO of Tradeshift. “With a combined 70 years of experience, Janet, Tony, Henry and Raphael will successfully lead the charge on tackling the aggressive and ambitious goals we have set out for ourselves and will no doubt make this the most successful year we’ve seen at Tradeshift.”
About Tradeshift
Tradeshift drives supply chain innovation for the digitally connected economy. As the leader in supply chain payments and marketplaces, the company helps buyers and suppliers digitize all their trade transactions, collaborate on every process, and connect with any supply chain app. More than 1.5 million companies across 190 countries trust Tradeshift to process over half a trillion USD in transaction value, making it the largest global business network for buying and selling. Discover commerce for all at tradeshift.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200210005298/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
Torq Secures $140M Series D at $1.2B Valuation to Lead the AI SOC and Agentic AI Era11.1.2026 17:59:00 CET | Press release
Fueled by Massive Customer Adoption of AI Agents, Torq Scales the World’s First True AI SOC Platform and Accelerates Expansion into the U.S. Federal Market Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D funding round, propelling its valuation to $1.2 billion and total funding to $332M. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260112510774/en/ Led by Merlin Ventures—a leading cybersecurity fund renowned for its deep access to the U.S. commercial and Public Sector markets—with participation from all existing investors, including Evolution Equity Partners, Notable Capital, Bessemer Venture Partners, Insight Ventures Partners, and Greenfield Partners, this capital injection is a definitive investment in the future of security. Torq is driving the industry’s critical shift: the complete transformation of the Security Operations Center (SOC) through
Andersen udvider sine kompetencer med tilføjelsen af Scimitar9.1.2026 21:44:00 CET | Pressemeddelelse
Andersen Consulting har indgået en samarbejdsaftale med Scimitar, der er et firma med fokus på at accelerere innovation i biovidenskabsbranchen. Scimitar, der har hovedkvarter i USA, et førende konsulenthus inden for strategieksekvering for biovidenskabsbranchen. Virksomheden er specialiseret i design af driftsmodeller, digital transformation og organisatorisk forandring. Scimitar samarbejder med medicinal- og biotech-virksomheder om at accelerere innovation, styrke den driftsmæssige eksekvering og sikre compliance gennem hele produkters livscyklus. Deres praktiske og samarbejdsorienterede tilgang sikrer løsninger, der ikke blot er formålstjenlige, men også skalerbare. "Virksomheder inden for biovidenskabsbranchen befinder sig i en tid med hurtige videnskabelige fremskridt, stigende regulatorisk kompleksitet og et voksende behov for operationel agilitet, samtidig med at de holdes op mod de højeste standarder for patientsikkerhed og dataintegritet," udtaler Ramy Khalil, CEO i Scimitar.
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom